Higher Levels Of Vitamin B6, Common Amino Acid Associated With Lower Risk Of Lung Cancer
06/19
An analysis that included nearly 400,000 participants finds that those with higher blood levels of vitamin B6 and the essential amino acid methionine (found in most protein) had... |
Bayer And OncoMed Pharmaceuticals Enter Strategic Alliance To Develop Anti-Cancer Stem Cell Therapeutics
06/19
|
Expression Of Certain Transporter Proteins May Predict Resistance To Drug Therapy
06/19
Rome, Italy, Friday 18 June: The expression of a transporter protein called the Breast Cancer Resistance Protein (BCRP) in rheumatoid arthritis (RA) patients may indicate higher... |
Taking Aim At Metastatic Lung Tumors
06/19
A new study uses a sophisticated genomic analysis to unravel some of the complex cellular signals that drive the deadly invasive spread of lung cancer. The research, published by ... |
Combined BRAF-Targeted And Immunotherapy Shows Promise For Melanoma Treatment
06/19
PHILADELPHIA — Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to ...
|
BRAF Inhibitor Shows Promising Preclinical Activity Against Melanoma
06/19
PHILADELPHIA — Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited... |
1st International Symposium On Deuterium Depletion - Deuterium Depletion: A New Possibility In Health Science
06/19
Budapest,
Hungary, 16 June 2010 / b3c newswire / - 1st International Symposium
on Deuterium Depletion was held on 13-14 May 2010 in Budapest,
Hungary. The conference... |
OncoMed Pharmaceuticals And Bayer Schering Pharma Announce Strategic Alliance To Develop Anti-Cancer Stem Cell Therapeutics
06/19
|
Oncolytics Biotech? Inc. Announces Issuance Of 35th U.S. Patent
06/19
CALGARY, June 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") today announced that it has been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for ... |
UC San Diego Brain Tumor Treatment Program Launches Personalized Biomarker Clinical Study
06/19
June 19 Moores UCSD Cancer Center Brain Tumor Unit Open House Offers Insight into Advancing Cancer Research
|
